These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35284540)

  • 1. Oligoadenylate synthetases-like is a prognostic biomarker and therapeutic target in pancreatic ductal adenocarcinoma.
    Chen S; Sun Z; Zhao W; Meng M; Guo W; Wu D; Shu Q; Chai J; Wang L
    Ann Transl Med; 2022 Feb; 10(3):138. PubMed ID: 35284540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling.
    Chen Q; Jiang LY; Cao C; Liu FY; Li DR; Wu PF; Jiang KR
    Mol Carcinog; 2024 May; 63(5):938-950. PubMed ID: 38353288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma.
    Huang X; Zhao L; Jin Y; Wang Z; Li T; Xu H; Wang Q; Wang L
    Front Oncol; 2022; 12():827051. PubMed ID: 35433491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma.
    Luan H; He Y; Zhang T; Su Y; Zhou L
    BMC Cancer; 2022 Apr; 22(1):463. PubMed ID: 35477379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
    Li J; Ke J; Fang J; Chen JP
    J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDX21 functions as a potential novel oncopromoter in pancreatic ductal adenocarcinoma: a comprehensive analysis of the DExD box family.
    Wu S; Sun X; Hua R; Hu C; Qin L
    Discov Oncol; 2024 Aug; 15(1):333. PubMed ID: 39095628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-10b inhibits migration and invasion of pancreatic ductal adenocarcinoma via regulating E2F7.
    Xu C; Qi X
    J Clin Lab Anal; 2020 Oct; 34(10):e23442. PubMed ID: 32592206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma.
    Wu M; Li X; Liu R; Yuan H; Liu W; Liu Z
    J Cancer; 2020; 11(21):6299-6318. PubMed ID: 33033514
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma.
    Cai W; Bao W; Chen S; Yang Y; Li Y
    Cancer Cell Int; 2021 Dec; 21(1):698. PubMed ID: 34930261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-Specific Protease 43 Impacts Pancreatic Ductal Adenocarcinoma Prognosis by Altering Its Proliferation and Infiltration of Surrounding Immune Cells.
    Zhao Z; Lin Z; Guo X; Al-Danakh A; He H; Qin H; Ma C; Zhang N; Tan G
    J Immunol Res; 2023; 2023():4311388. PubMed ID: 37050932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics landscape of Interferon-stimulated gene OASL reveals a potential biomarker in pan-cancer: from prognosis to tumor microenvironment.
    Liu Y; Yang R; Zhang M; Yang B; Du Y; Feng H; Wang W; Xue B; Niu F; He P
    Front Immunol; 2024; 15():1402951. PubMed ID: 39286258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new prognosis prediction model combining TNM stage with MAP2K4 and JNK in postoperative pancreatic cancer patients.
    Liu XD; Zhang ZW; Wu HW; Liang ZY
    Pathol Res Pract; 2021 Jan; 217():153313. PubMed ID: 33341545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLE2 is associated with favorable prognosis and regulates cell growth and gemcitabine sensitivity in pancreatic cancer.
    Hu S; Chen Z; Gu J; Tan L; Zhang M; Lin W
    Ann Transl Med; 2020 Aug; 8(16):1017. PubMed ID: 32953817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic landscape of prognostic value in pancreatic ductal adenocarcinoma microenvironment.
    Pu N; Chen Q; Gao S; Liu G; Zhu Y; Yin L; Hu H; Wei L; Wu Y; Maeda S; Lou W; Yu J; Wu W
    Ann Transl Med; 2019 Nov; 7(22):645. PubMed ID: 31930046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated Expression of TUBA1C Predicts Poor Prognosis and Promotes Oncogenesis in Pancreatic Ductal Adenocarcinoma via Regulating the Cell Cycle.
    Albahde MAH; Zhang P; Zhang Q; Li G; Wang W
    Front Oncol; 2020; 10():49. PubMed ID: 32117719
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
    Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L
    Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma.
    Li SS; Jiang WL; Xiao WQ; Li K; Zhang YF; Guo XY; Dai YQ; Zhao QY; Jiang MJ; Lu ZJ; Wan R
    World J Gastrointest Oncol; 2019 Aug; 11(8):599-621. PubMed ID: 31435462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer.
    Okazaki J; Tanahashi T; Sato Y; Miyoshi J; Nakagawa T; Kimura T; Miyamoto H; Fujino Y; Nakamura F; Takehara M; Ma B; Bando M; Kitamura S; Okamoto K; Muguruma N; Sogabe M; Takayama T
    Digestion; 2020; 101(6):794-806. PubMed ID: 31563901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.